Fallout from Iran's actions were to an extent priced in by markets
The Dubai Health Authority (DHA) on Tuesday announced it was approving a longer interval period between doses for the Oxford-AstraZeneca Covid vaccine.
Listen to this story and more on 8@8 with David Light
"Based on recent studies from the University of Oxford on the Oxford-AstraZeneca vaccine and as per the recommendations of the WHO, DHA has approved a 10-week interval between the 1st & 2nd dose of the Oxford-AstraZeneca vaccine," the authority said in a post published on its official social media account.
Recent studies showed a higher efficacy and higher acquired immunity when the dosing interval between the first and second doses was increased, it explained.
"All those who are due for the second dose of this vaccine will receive a text message with the date and location for their vaccination appointment," it added.
On February 2, the UAE announced it would start offering the India-made AstraZeneca Covid-19 vaccines as part of its national vaccination programme.
It is the fourth vaccine being offered in the UAE, apart from Sinopharm, Pfizer-BioNTech, and Sputnik V.
Fallout from Iran's actions were to an extent priced in by markets
DXB said in a statement that airport 'recovery will take some time' after there was flooding caused by rainwater on the runway
The 22-time Grand Slam title winner was returning to action for the first time after missing most of the 2023 season
For the company's founders, it was a way to give back to the community
Unlocking Holistic Health: Camp to address all acute and chronic issues
Pizza Di Rocco expands into new communities
World No 3 focused on winning in Stuttgart, Madrid or Rome to get a title on the surface under her belt
Roads were shut and stern warnings were issued as the country experienced extreme weather conditions